Webyour own risk and is subject to BC Cancer's terms of use availableat www.bccancer.bc.ca/terms-of-use BC Cancer Protocol Summary for the Treatment of … Webyour own risk and is subject to BC Cancer's terms of use available at www.bccancer.bc.ca/terms-of-use BC Cancer Protocol Summary for the Treatment of …
JNCCN 360 - MM - Daratumumab (Darzalex ® )
WebRefer to the BC Cancer Drug Manual for more information. 5. Neuropathy: Dose modification or discontinuation may be required. Refer to the BC Cancer Drug Manual … WebAug 29, 2024 · Initial approval of daratumumab in 2015 was for use as a single agent. 10 However, studies of daratumumab in combination with either a PI or an iMID (plus dexamethasone) demonstrated efficacy, and today most patients in myeloma programs receive the mAB as part of a combination regimen. 11–13 “Those of us who work in high … richard zaback
DRUG NAME: Daratumumab - BC Cancer
http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Bortezomib_monograph.pdf WebA total of 583 MM patients who received dara-based therapy in second-line or later treatment were included. After a median follow-up of 17.5 months, the median … Web(dar” oh loo’ ta mide) is a drug that is used to treat prostate cancer. It blocks the effect of testosterone which is a male sex hormone that may stimulate the growth of prostate … redness in eye with discharge